(Q36917923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Francisco Veiga

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Ana Francisca Soares

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

183-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Design of nanoparticles composed of graft copolymers for oral peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Development of oral insulin: progress and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Magnetically responsive polymeric microparticles for oral delivery of protein drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Transporters and drug therapy: implications for drug disposition and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Protein aggregation and its inhibition in biopharmaceutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Strategies for delivery of peptides utilizing absorption-enhancing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Peptide transporters in the intestine and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Mechanism of inhibition of proton: dipeptide co-transport during chronic enteritis in the mammalian small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Tight junction modulation and its relationship to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Drugs as P-glycoprotein substrates, inhibitors, and inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Beta-cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Cell interaction studies of PLA-MePEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

The effect of physical barriers and properties on the oral absorption of particulates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Polysaccharide-decorated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Cyclodextrins: their future in drug formulation and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Cyclodextrins in drug delivery: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Cyclodextrins in oligonucleotide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Structural background of cyclodextrin-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Association complexes between ovalbumin and cyclodextrins have no effect on the immunological properties of ovalbumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

The Effect of Cyclodextrins on the In Vitro and In Vivo Properties of Insulin‐Loaded Poly (D,L‐Lactic‐Co‐Glycolic Acid) Microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

In vivo absorption studies of insulin from an oral delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Amphiphilic beta-cyclodextrins modified on the primary face: synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

A practical synthesis of amphiphilic cyclodextrins fully substituted with sugar residues on the primary face

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Synthesis and characterisation of novel nanospheres made from amphiphilic perfluoroalkylthio-beta-cyclodextrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Direct Investigation of the Vectorization Properties of Amphiphilic Cyclodextrins in Phospholipid Films

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Optimization of entrapment of metronidazole in amphiphilic beta-cyclodextrin nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Nanoparticles of beta-cyclodextrin esters obtained by self-assembling of biotransesterified beta-cyclodextrins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Influence of chemical structure of amphiphilic beta-cyclodextrins on their ability to form stable nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Cytotoxic evaluation of injectable cyclodextrin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Novel heterotopic colloids of anionic porphyrins entangled in cationic amphiphilic cyclodextrins: spectroscopic investigation and intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic beta-cyclodextrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Direct formation of nanospheres from amphiphilic beta-cyclodextrin inclusion complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Recognition-induced supramolecular porous nanosphere formation from cyclodextrin conjugated by cholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.2.183

21 January 2018

Identifiers

DOI

10.2217/17435889.2.2.183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17716120%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference